Remaining Proceeds. The Company shall instruct the Tail Loss Trustee to release the remaining monies in the Tail Loss Trust to the Subscribing Reinsurer within twenty (20) business days of the Tail Loss Termination Date.
Remaining Proceeds. Any remaining proceeds in case of suits with respect to an enforcement proceeding relating to any Shared Product or Companion Diagnostic under this Section 10.3, shall be shared by the Parties in accordance with the Profit & Loss Share or, if obtained on or after the Vividion Opt-Out Date, the Party bringing suit under this Section 10.3 shall retain [***] percent ([***]%) and the other Party shall retain [***] percent ([***]%) of such amount.
Remaining Proceeds. The remainder of any recovery or distribution received by a Party under this Section 10.1, after reimbursement of costs and expenses of each Party, shall be distributed as follows: (i) if Moderna is the enforcing Party, Moderna shall receive [**] percent ([**]%) and Carisma shall receive [**] percent ([**]%); and (ii) if Carisma is the enforcing Party, Carisma shall retain [**] percent ([**]%).
Remaining Proceeds. As of the date hereof, to the Knowledge of the Citadel Parties, the Remaining Proceeds (as defined in Section 4.13(b)) will be sufficient to pay each holder of common stock of Citadel $0.52 per share in the aggregate.
Remaining Proceeds. Any remaining proceeds in case of suits with respect to a Co-Co Enforcement Proceeding or a Co-Co Step-In Proceeding relating to any Co-Co Product or related Co-Co Diagnostic Product under this Section 6.5, shall, (A) with respect to such suits in the ROW Territory, be allocated between the Parties such that the Party bringing suit under this Section 6.5 retains [***] and the other Party retains [***] of such amount, and (B) with respect to suits in the U.S., shall be shared by the Parties in accordance with the Profit & Loss Share.
Remaining Proceeds. Any remaining proceeds in case of suits with respect to a Licensed Enforcement Proceeding or a Licensed Step-In Proceeding relating to any Licensed Product or related Licensed Diagnostic Product under this Section 4.5, shall be retained by the Party bringing suit under this Section 4.5 or, if damages are recovered for infringement of both Jounce Licensed Collaboration Patents and Celgene PD-1 Patents, then such remaining proceeds shall be shared equally by the Parties.
Remaining Proceeds. If there are Escrowed Funds remaining after final payment, those funds which are the proceeds of a Lead Hazard Reduction Demonstration Grant Program Loan shall be applied as a principal reduction to the outstanding balance of the loan.
Remaining Proceeds. Any remaining proceeds in case of suits with respect to an enforcement proceeding relating to any Product under this Section 10.3, shall be shared by the Parties in accordance with the Profit & Loss Share.
Remaining Proceeds. After the Obligations have been paid in full in cash (the payment in full in cash of such Obligations, to the extent relating to amounts due to the holders, to be evidenced to the Collateral Agent by written certification from the holders), the balance of the proceeds of the Collateral, if any, shall be paid to the Issuer or as otherwise required by law.
Remaining Proceeds. If there are Escrowed Funds remaining after final payment, those funds shall be returned to the provider of the unexpended funds
